Stilla Technologies, a France based SJE Group investment and provider of pioneering digital PCR solutions for high-precision genetic analysis, will be exhibiting at the following global events during January and February 2020:
Advanced in Liquid Biopsies 13-16th of January 2020, Miami (USA)
10th Assises de génétique Humaine et Médicale 21-24th of January 2020, Tours (France)
SLAS US 2020 25-29th of January 2020, San Diego (USA)
Annual Congress on Advances in Biotechnology 17-18th of February 2020, Paris (France)
ABRF 2020 Annual Meeting 29th February-03rd of March 2020, Palm Springs (USA)
The SJE Group wishes the Stilla team the very best.
About Stilla Technologies
Founded in 2013 at Ecole Polytechnique, Stilla Technologies is a Paris-based life sciences company focused on accelerating the development of next-generation genetic tests by providing a groundbreaking and flexible digital PCR solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla technologies aims to make dPCR a lab commodity for all areas of the life sciences. Stilla actively advises and supports its customers worldwide through its dynamic and multidisciplinary R&D team, with expertise spanning from microfluidics to chemistry, including molecular biology and AI.